The site where students compete, learn, and make money Friday, May 16, 2008
DJIA: 94.28 NASD: 37.03 10-YR: -0.095
 
 
 
 
     
 
     

Contests

Leaderboard - Portfolio

Current Balance: $13409.80
symbolnumber of sharesbuying pricecurrent pricenet change
PS WATER RESOURCE (PHO)100019.4721.89 $2,420.00 (12.43%)info - chart
NATL OILWELL VARC (NOV)10057.2776.22 $1,895.00 (33.09%)info - chart
GOL LINHAS AEREAS (GOL)100020.7016.52 $-4,180.00 (-20.19%)info - chart
GILEAD SCIENCES (GILD)20047.850.00 $-9,570.00 (-100%)info - chart
POWERSHARES DB AG (DBA)25034.940.00 $-8,735.00 (-100%)info - chart
JOHNSON AND JOHNS (JNJ)25062.6566.68 $1,007.50 (6.43%)info - chart
Portfolio Value:$76111.8 (-23.89%)

Related News

Comments


National Oilwell Varco, Inc. (NYSE:NOV) ? Company news alert ...
Research Oracle, UK - May 12, 2008
National Oilwell Varco, Inc.?s (NOV) NYSE common stock has increased 33.9% since our last update report, due to rising crude oil prices and the company?s ...
 

GOL Linhas Aereas Inteligentes SA (NYSE:GOL) ? Company news alert ...
Research Oracle, UK - Apr 30, 2008
GOL Linhas Aereas Inteligentes? (GOL) 1Q 08 revenues were in line with our estimate, while profitability was significantly below our estimate. ...
 

Gilead Sciences to Present at the 2008 Citi Investment Research ...
WELT ONLINE, Germany - May 14, 2008
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 2008 Citi Investment Research Global ...
 

Are You Wrecking Your Retirement?
Motley Fool - May 14, 2008
Lots of public companies offer this feature, and if you work for companies like Google (Nasdaq: GOOG), Johnson & Johnson (NYSE: JNJ), Dow Chemical (NYSE: ...
 

Abbott Knocks Down Boston Scientific
Motley Fool - May 14, 2008
... that Abbott's second-generation stent is better than the stents that Boston Scientific and Johnson & Johnson (NYSE: JNJ) have been selling for years. ...
Abbott Poised To Take Over The Market Forbes
all 72 news articles
 

VIDEO from Medialink and Johnson & Johnson: From Molecule to Medicine
PR Newswire (press release), NY - 17 hours ago
... through the pharmaceutical R&D process. (See video from Johnson & Johnson (NYSE: JNJ) at: http://jnj.mediaseed.tv/Story.aspx?story=35096) 05NY08-0074.
 

Stocks to Watch for Thursday: UDTT, GILD, JNJ, GOOG
FOXBusiness - Apr 24, 2008
Our list includes: Universal Detection Technology (OTCBB: UDTT), Gilead Sciences, Inc. (NASDAQ: GILD), Johnson & Johnson (NYSE: JNJ), Google Inc. (NASDAQ: ...
 

Gilead Sciences' Board Member Establishes Rule 10b5-1 Stock ...
WELT ONLINE, Germany - May 13, 2008
Gilead Sciences, Inc. (Nasdaq:GILD) today announced the establishment of a new stock trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934 ...
 

Grow Old or Die Trying
Motley Fool - May 13, 2008
But even at 50 years of age, maximizing your IRA contributions into a conservative fund, into some high-quality companies like Johnson & Johnson (NYSE: JNJ) ...
 

Omrix's Wild Ride
Motley Fool - May 13, 2008
The biggest surge came from its biosurgical products, as its marketing partner, Johnson & Johnson (NYSE: JNJ), began to sell more Evicel -- its fibrin ...
 

DBA

Still up, nice.